|25.54||+0.5300||+2.12%||Vol 250.12K||1Y Perf -25.54%|
|Oct 4th, 2023 15:57 DELAYED|
|- -%||- -|
|Target Price||40.40||Analyst Rating||Moderate Buy 1.88|
|Potential %||58.74||Finscreener Ranking||★★★★+ 57.13|
|Insiders Trans % 3/6/12 mo.||-/-100/-100||Value Ranking||★★★★★ 62.61|
|Insiders Value % 3/6/12 mo.||-/-100/-100||Growth Ranking||★★★★★ 66.83|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||25.69||Earnings Rating||Strong Sell|
|Market Cap||914.40M||Earnings Date||1st Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||1st Nov 2023|
|Estimated EPS Next Report||0.40|
|EPS Growth Next 5 Years %||6.00|
|Avg. Weekly Volume||303.07K|
|Avg. Monthly Volume||431.99K|
|Avg. Quarterly Volume||503.61K|
Cross Country Healthcare Inc. (NASDAQ: CCRN) stock closed at 25.01 per share at the end of the most recent trading day (a -0.36% change compared to the prior day closing price) with a volume of 287.38K shares and market capitalization of 914.38M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Business Services industry, Industrials sector and employs 1700 people. Cross Country Healthcare Inc. CEO is Kevin Clark.
The one-year performance of Cross Country Healthcare Inc. stock is -25.54%, while year-to-date (YTD) performance is -5.87%. CCRN stock has a five-year performance of 186.16%. Its 52-week range is between 20.5001 and 40.12, which gives CCRN stock a 52-week price range ratio of 25.69%
Cross Country Healthcare Inc. currently has a PE ratio of 4.80, a price-to-book (PB) ratio of 2.53, a price-to-sale (PS) ratio of 0.48, a price to cashflow ratio of 19.20, a PEG ratio of 0.80, a ROA of 34.34%, a ROC of 53.06% and a ROE of 74.95%. The company’s profit margin is 6.87%, its EBITDA margin is 11.00%, and its revenue ttm is $2.18 Billion , which makes it $58.41 revenue per share.
Of the last four earnings reports from Cross Country Healthcare Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.40 for the next earnings report. Cross Country Healthcare Inc.’s next earnings report date is 01st Nov 2023.
The consensus rating of Wall Street analysts for Cross Country Healthcare Inc. is Moderate Buy (1.88), with a target price of $40.4, which is +58.74% compared to the current price. The earnings rating for Cross Country Healthcare Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cross Country Healthcare Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Cross Country Healthcare Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 27.76, ATR14 : 0.77, CCI20 : 72.30, Chaikin Money Flow : -0.03, MACD : 0.13, Money Flow Index : 77.40, ROC : 3.69, RSI : 53.62, STOCH (14,3) : 68.62, STOCH RSI : 0.25, UO : 55.52, Williams %R : -31.38), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cross Country Healthcare Inc. in the last 12-months were: Cynthia Ann Grieco (Sold 1 071 shares of value $38 556 )
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.